Surgical Innovations Group plc provided earnings guidance for the full year ending December 31, 2014. For the period, the board expects that the company will report a significant loss before tax. Against this backdrop, short-term working capital funding and cash generation remains the board's key priority and further updates will be provided to shareholders as appropriate.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5 GBX | 0.00% | 0.00% | -16.67% |
04-18 | Stocks recover some of recent Fed talk losses | AN |
04-18 | Surgical Innovations Group Bags UK Distribution Contracts | MT |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.67% | 5.94M | |
-5.56% | 181B | |
-0.11% | 108B | |
-6.17% | 66.12B | |
+2.64% | 50.65B | |
+6.58% | 43.11B | |
+3.40% | 41.3B | |
+21.98% | 31.6B | |
+16.81% | 25.03B | |
-5.81% | 24.16B |
- Stock Market
- Equities
- SUN Stock
- News Surgical Innovations Group plc
- Surgical Innovations Group plc Provides Earnings Guidance for the Full Year Ending December 31, 2014